SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-166655
Filing Date
2015-05-01
Accepted
2015-05-01 17:20:35
Documents
1
Group Members
BAXALTA GMBH

Document Format Files

Seq Description Document Type Size
1 SC 13G d917361dsc13g.htm SC 13G 68384
  Complete submission text file 0001193125-15-166655.txt   70029
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 15825586
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BAXTER PARKWAY DEERFIELD IL 60015
Business Address ONE BAXTER PARKWAY DEERFIELD IL 60015 224-948-2000
Baxalta Inc (Filed by) CIK: 0001620546 (see all company filings)

IRS No.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations